The purpose of this Core is to provide to all Projects of the P01 with the high degree of research and clincial imaging support required to facilitate the collection of image guided surgical specimens and the serial assessment of response to therapy. Core functions will include the development of new methods, translation and maintenance of technologies developed in the Projects from the current and upcoming cycles into the clinic. The Core will comprise experienced investigators with broad expertise and a proven track record in working together, as well as with their collaborators. There are five major aims: (1) To translate the advanced MR data acquisition protocols and pulse sequences developed in the current cycle of the P01 from research to clinical scanners and to provide ongoing maintenance for them in order to accommodate changes in clinical practice, as well as updates to the scanner hardware or software. (2) To develop and maintain post-processing capabilities for analysis, visualization and interpretation of the multi-parametric and multi-dimensional imaging examinations used in Projects 1, 2 and 3 with a special emphasis on providing consistent and reliable metrics to describe tumor heterogeneity and spatial extent. (3) To support the acquisition and analysis of pre-surgery imaging data, the selection of targets of interest and the collection of image guided tissue samples from patients with GBM so that tumor heterogeneity can be studied in the context of imaging, histological and genomic properties as required in Projects 1, 2 and 3. (4) To provide improved quantitative analysis methods that will facilitate the integration of physiologic and metabolic MR parameters into the current RANO criteria and hence provide a more reliable and consistent assessment of changes in tumor burden for patients with GBM who are participating in Projects 1 and 3. (5) To develop a multi-faceted, multi-layered, and multi-disciplinary database of GBM characteristics of information from histopathology, immunohistochemistry, genomics, animal models, physiologic and metabolic imaging, and clinical information to allow all Projects to perform a systematic analysis of their data.

Public Health Relevance

The Core will improve the management of patients with glioblastoma by working with the Research Project and other Cores to translate and integrate novel methods developed as part of the current and upcoming cycle of the P01 with the currnt standard of care. New algorithms and data processing strategies will be developed to define targets for obtaining image guided tissue samples and assess response to therapy..

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA118816-07
Application #
8738075
Study Section
Special Emphasis Panel (ZCA1-RPRB-2)
Project Start
2014-08-01
Project End
2018-07-31
Budget Start
2014-08-01
Budget End
2015-07-31
Support Year
7
Fiscal Year
2014
Total Cost
$251,724
Indirect Cost
$92,175
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Mancini, Andrew; Xavier-Magalhães, Ana; Woods, Wendy S et al. (2018) Disruption of the ?1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner. Cancer Cell 34:513-528.e8
Vareth, Maryam; Lupo, Janine; Larson, Peder et al. (2018) A comparison of coil combination strategies in 3D multi-channel MRSI reconstruction for patients with brain tumors. NMR Biomed 31:e3929
Li, Yan; Lafontaine, Marisa; Chang, Susan et al. (2018) Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma. ACS Chem Neurosci 9:130-137
Gordon, Jeremy W; Chen, Hsin-Yu; Autry, Adam et al. (2018) Translation of Carbon-13 EPI for hyperpolarized MR molecular imaging of prostate and brain cancer patients. Magn Reson Med :
Choi, Serah; Yu, Yao; Grimmer, Matthew R et al. (2018) Temozolomide-associated hypermutation in gliomas. Neuro Oncol 20:1300-1309
Park, Ilwoo; Larson, Peder E Z; Gordon, Jeremy W et al. (2018) Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies. Magn Reson Med 80:864-873
Hayes, Josie; Yu, Yao; Jalbert, Llewellyn E et al. (2018) Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas. Neuro Oncol 20:632-641
Anwar, Mekhail; Molinaro, Annette M; Morin, Olivier et al. (2017) Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI. Radiat Res 188:303-313
Venkatesan, Subramanian; Swanton, Charles; Taylor, Barry S et al. (2017) Treatment-Induced Mutagenesis and Selective Pressures Sculpt Cancer Evolution. Cold Spring Harb Perspect Med 7:
Zou, Xiaowei; Hart, Blaine L; Mabray, Marc et al. (2017) Automated algorithm for counting microbleeds in patients with familial cerebral cavernous malformations. Neuroradiology 59:685-690

Showing the most recent 10 out of 75 publications